Lam Research holder Timothy Archer plans $9.6M sale
A Lam Research Corp insider filed a Rule 144 notice to sell 30,000 common shares tied to a stock option exercise, with additional sales reported in the prior three months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LAM RESEARCH CORP (LRCX) has a planned sale of restricted securities by Timothy M. Archer under Rule 144. The notice covers the proposed sale of 30,000 shares of common stock through Fidelity Brokerage Services LLC, expected around September 9, 2026, in connection with a stock option exercise. Archer also reported Rule 144 sales of 30,000 shares on July 2, 2026 and 30,000 shares on August 6, 2026.
Key Figures
Key Terms
Rule 144 regulatory
stock option exercise financial
aggregate market value financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for LRCX?
What prior LRCX sales by Timothy Archer are listed in the last three months?
What is the approximate date and method of the new LRCX sale?
Who is executing the planned LRCX stock sale for Timothy Archer?
AI-generated analysis. How Rhea-AI works. Not financial advice.